Catharina Lurken

Candy is a Partner at Monitor Deloitte’s Strategy Practice within the Life Sciences & Health Care (LSHC) Industry. She has nearly 30 years of global pharmaceutical industry and strategic consulting experience, focusing on realizing growth opportunities and supporting the globalization journey for clients across the US, EU and Asia.

In addition to her global client project work, she has co-led the shaping and growth of Deloitte's German LSHC practice for 2+ years. Currently, she leads a cohort of Japan HQ Life Sciences Companies in the US, which provides tailored offerings and by resources who understand the Japanese business culture and know how to navigate between Japanese and American stakeholders and interests. As part of her role, she helps her clients navigate their journey towards globalization as they expand their portfolio increasingly overseas.

In addition, she manages Deloitte's Global practice’s Therapeutic Area Transformation and Portfolio Strategy Services, including running an offshore Center in India. This center is comprised of in-house TA experts who closely collaborate with local internal and externa subject matter advisors worldwide. Her therapeutic area expertise includes Oncology, Hematology, Rare Diseases, Immunology, Women's Health, Infectious Diseases, Neurology, Respiratory, GI, CV and Diabetes.

Candy has been leading multiple initiatives to support women within the industry through both internal and external mentoring programs. In addition, she received the HBA (Healthcare Businesswomen’s Association) Luminary award for Deloitte in 2019. 

Candy is fluent in English, German and Dutch (native). She holds an EU & U.S. Executive MBA degree with honors from Rochester University, Simon School of Business, Rochester, NY (US), and Nyenrode University, Breukelen (The Netherlands).